Norris MD - Search Results

1

Two cases of hypereosinophilia and high-risk acute lymphoblastic leukemia.

Sutton R, Lonergan M, Tapp H, Venn NC, Haber M, Norris MD, O'Brien TA, Alvaro F, Revesz T. Sutton R, et al. Among authors: norris md. Leukemia. 2008 Jul;22(7):1463-5. doi: 10.1038/sj.leu.2405096. Epub 2008 Jan 17. Leukemia. 2008. PMID: 18200036 No abstract available.

2

Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.

Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BW. Haber M, et al. Among authors: norris md. Cancer Res. 1989 Oct 1;49(19):5281-7. Cancer Res. 1989. PMID: 2569932

3

Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression.

Norris MD, Haber M, King M, Davey RA. Norris MD, et al. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1435-41. doi: 10.1016/0006-291x(89)92764-2. Biochem Biophys Res Commun. 1989. PMID: 2575383

4

Therapy-induced drug resistance in a human leukemia line (LALW-2). A clinically relevant model.

White L, Haber M, Brian MJ, Norris MD, Trickett A, Sosula L, Tiley C, Stewart BW. White L, et al. Among authors: norris md. Cancer. 1989 Jun 1;63(11):2103-10. doi: 10.1002/1097-0142(19890601)63:11<2103::aid-cncr2820631106>3.0.co;2-n. Cancer. 1989. PMID: 2720561

5

Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate.

Haber M, Reed C, Kavallaris M, Norris MD, Stewart BW. Haber M, et al. Among authors: norris md. J Natl Cancer Inst. 1989 Aug 16;81(16):1250-4. doi: 10.1093/jnci/81.16.1250. J Natl Cancer Inst. 1989. PMID: 2754745

6

Detection of evolving immunoglobulin heavy-chain gene rearrangements in acute lymphoblastic leukemia: a PCR-based assay employing overlapping DJH primers.

Norris MD, Kwan E, Haber M, Marshall GM. Norris MD, et al. Leukemia. 1995 Oct;9(10):1779-82. Leukemia. 1995. PMID: 7564525

7

An assay for the determination of reduced methotrexate accumulation in cells displaying limited viability in vitro.

Haber M, Norris MD, Kavallaris M, Camacho M, Madafiglio J, Baker CJ, White L, Stewart BW. Haber M, et al. Among authors: norris md. Cancer Lett. 1995 Oct 20;97(1):49-55. doi: 10.1016/0304-3835(95)03950-2. Cancer Lett. 1995. PMID: 7585477

8

Analysis of a novel cDNA encoding a C219-reactive peptide isolated from methotrexate-selected multidrug-resistant human leukemic cells.

Norris MD, Gilbert J, Madafiglio J, Haber M. Norris MD, et al. Gene. 1995 Apr 24;156(2):313-4. doi: 10.1016/0378-1119(94)00541-y. Gene. 1995. PMID: 7758977

9

Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine.

Haber M, Madafiglio J, Norris MD. Haber M, et al. Among authors: norris md. J Cancer Res Clin Oncol. 1993;119(6):315-7. doi: 10.1007/BF01208836. J Cancer Res Clin Oncol. 1993. PMID: 8449966

10

Sensitive non-radioactive PCR detection of clonal T-cell receptor-gamma gene rearrangements in childhood acute lymphoblastic leukaemia.

Haber M, Kwan E, Zhu L, Marshall GM, Norris MD. Haber M, et al. Among authors: norris md. Br J Haematol. 1997 Sep;98(4):995-8. doi: 10.1046/j.1365-2141.1997.3243143.x. Br J Haematol. 1997. PMID: 9326201 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters